Ubs Asset Management Americas Inc Arcturus Therapeutics Holdings Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 180,398 shares of ARCT stock, worth $3.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180,398
Previous 25,954
595.07%
Holding current value
$3.96 Million
Previous $818,000
644.74%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARCT
# of Institutions
196Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$103 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$60.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$43 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$37.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$30.4 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $583M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...